Cargando…
Correction: Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141100/ https://www.ncbi.nlm.nih.gov/pubmed/30222767 http://dx.doi.org/10.1371/journal.pone.0204463 |
Ejemplares similares
-
Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
por: Brown, Christine E., et al.
Publicado: (2013) -
Correction to: Design considerations of an IL13Rα2 antibody–drug conjugate for difuse intrinsic pontine glioma
por: Lian, Xiaolei, et al.
Publicado: (2021) -
Expression of IL4Rα and IL13Rα1 are associated with poor prognosis of soft-tissue sarcoma of the extremities, superficial trunk, and retroperitoneum
por: Kim, Kyoung Min, et al.
Publicado: (2021) -
Expression of IL-13Rα2 and FUS in glioma: clinicopathological and prognostic correlation
por: Cheng, Guang, et al.
Publicado: (2023) -
A STAT3 Gene Expression Signature in Gliomas is Associated with a Poor Prognosis
por: Alvarez, James V., et al.
Publicado: (2007)